Kolon TissueGene Inc
950160
Company Profile
Business description
Kolon TissueGene Inc is a biopharmaceutical company that develops regenerative therapies for the treatment of various orthopedic disorders. It is developing four product candidates, TG-C, TG-B, TG-D and TG-N for regeneration of cartilage, bone, disc and nerve.
Contact
9713 Key West Avenue
Suite 300
RockvilleMD20850
USAT: +1 301 921-6000
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
58
Stocks News & Analysis
stocks
Going into earnings, is Microsoft stock a buy, a sell, or fairly valued?
With recent structural changes and strong Azure performance, here’s what we think of Microsoft stock.
stocks
Tesla earnings: Shares fall as market focuses on uncertainty in near term
Are shares overpriced despite the fall?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,317.20 | 26.50 | -0.28% |
| CAC 40 | 8,200.14 | 25.64 | -0.31% |
| DAX 40 | 24,205.75 | 2.04 | -0.01% |
| Dow JONES (US) | 47,015.13 | 280.52 | 0.60% |
| FTSE 100 | 9,586.57 | 8.00 | 0.08% |
| HKSE | 26,160.15 | 192.17 | 0.74% |
| NASDAQ | 23,176.94 | 235.14 | 1.02% |
| Nikkei 225 | 49,299.65 | 658.04 | 1.35% |
| NZX 50 Index | 13,391.59 | 14.49 | 0.11% |
| S&P 500 | 6,790.06 | 51.62 | 0.77% |
| S&P/ASX 200 | 9,019.00 | 25.20 | -0.28% |
| SSE Composite Index | 3,950.31 | 27.90 | 0.71% |